News

Kogi State Government has taken a far-reaching decision in the education sector by outlawing signing-out ceremonies in all tertiary institutions of the state. ‎Similarly, the annual speech and ...
The Federal Government said it completed a comprehensive review of school curricula for basic, senior secondary and technical education aimed to make Nigerian learners “future-ready.” The Ministry of ...
The immediate impact of recent U.S. tariffs on Indian exports may appear limited, but their secondary and tertiary effects on the economy pose challenges that must be addressed, the Finance Ministry ...
NEW DELHI: The finance ministry on Wednesday cautioned that while the immediate impact of US tariffs on Indian exports may be limited, their secondary and long-term effects could pose significant ...
(RTTNews) - Akeso Inc. reported positive results from Phase 3 clinical trial of gumokimab or AK111, a fully human anti-IL-17A monoclonal antibody, for the treatment of active ankylosing spondylitis.
An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can increase the risk of secondary tumors in the uterus. The study shows that ...
Current and former OpenAI employees plan to sell approximately $6 billion worth of shares to an investor group that includes Thrive Capital, SoftBank Group Corp. and Dragoneer Investment Group, in a ...
Various cities and towns across Utah will be voting in Tuesday’s primary election for mayoral spots and city council posts, among others that are on the ballot this year. The filing period for most of ...
Sleep solution startup The Sleep Company has raised Rs 480 crore ($56 million) in an equal mix of primary and secondary funding rounds, with ChrysCapital and 360 One Asset as lead investors. According ...
OpenAI is in early talks about a potential sale of stock for current and former employees at a valuation of about $500 billion, people briefed on the investment discussions said, marking an enormous ...
The phase 3 INDEPENDENCE trial (NCT04717414) evaluating luspatercept-aamt (Reblozyl) in adult patients with myelofibrosis-associated anemia receiving red blood cell (RBC) transfusions did not achieve ...
Consumers are now almost as likely to say they learn about new medications from advertisements on linear or connected TV as from their doctor, according to a new report. Predictive advertising company ...